Patents by Inventor Inhyeok JEONG

Inhyeok JEONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTICANCER PHARMACEUTICAL COMPOSITION CONTAINING IF1 AS ACTIVE INGREDIENT
    Publication number: 20240366716
    Abstract: The present invention pertains to an anticancer composition containing IF1 (ATPase inhibitory factor 1). The IF1 (ATPase inhibitory factor 1) according to the present invention has the effect of releasing extracellular ATP, induces cytotoxicity in various cancer cells and exhibits anticancer efficacy, and is thus very useful as an active ingredient of a powerful anticancer agent.
    Type: Application
    Filed: July 17, 2024
    Publication date: November 7, 2024
    Applicants: Korea University Research and Business Foundation, CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Min-Jeong SHIN, Hyeon Soo KIM, Inhyeok JEONG, Eun Hye YOO, Ji Hyung CHUNG
  • Anticancer pharmaceutical composition containing IF1 as active ingredient
    Patent number: 12059450
    Abstract: The present invention pertains to an anticancer composition containing IF1 (ATPase inhibitory factor 1). The IF1 (ATPase inhibitory factor 1) according to the present invention has the effect of releasing extracellular ATP, induces cytotoxicity in various cancer cells and exhibits anticancer efficacy, and is thus very useful as an active ingredient of a powerful anticancer agent.
    Type: Grant
    Filed: October 2, 2019
    Date of Patent: August 13, 2024
    Assignees: Korea University Research and Business Foundation, CHA UNIVERSITY INDUSTRY—ACADEMIC COOPERATION FOUNDATION
    Inventors: Min-Jeong Shin, Hyeon Soo Kim, Inhyeok Jeong, Eun Hye Yoo, Ji Hyung Chung
  • ANTICANCER PHARMACEUTICAL COMPOSITION CONTAINING IF1 AS ACTIVE INGREDIENT
    Publication number: 20210386822
    Abstract: The present invention pertains to an anticancer composition containing IF1 (ATPase inhibitory factor 1). The IF1 (ATPase inhibitory factor 1) according to the present invention has the effect of releasing extracellular ATP, induces cytotoxicity in various cancer cells and exhibits anticancer efficacy, and is thus very useful as an active ingredient of a powerful anticancer agent.
    Type: Application
    Filed: October 2, 2019
    Publication date: December 16, 2021
    Applicants: Korea University Research And Business Foundation, CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Min-Jeong SHIN, Hyeon Soo KIM, Inhyeok JEONG, Eun Hye YOO, Ji Hyung CHUNG